×
0.000123183050012206 0.000246366100024588 0.00135501355013549 0.000985464400098525 0.00217664449371762 -0.000184774575018484 -0.000739098300073938 -0.0024636610002464
Stockreport

Novartis Considers Selling Generic Dermatology Drugs Business [Investor's Business Daily]

ADVANCED ACCELERATOR APPLICATIONS SA AMERICAN DE (AAAP)  More Company Research Source: Investors Business Daily
Last advanced accelerator applications sa american de earnings: 8/31 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: adacap.com/investor-relations
PDF Technology Related news 10/31/2017 Mylan President Rajiv Malik was named in a sweeping lawsuit Tuesday alleging price-fixing. Incyte Rises On A Beat-And-Raise, Expanding Deal With AstraZeneca Lennar, Strayer, Dynegy Announce Deals; These May Be Next Biogen Dives Despite Topping Views; Lilly, Novartis Beat Does Gilead Now Have A New Multi-Billion-Dollar Franchise? Generic Drugmaker Soars 11%; Investors Warm Up To Merger Deal This Generic Drug Maker Dives As Much As 16% On Merger News Incyte Cancer Treatment Uses Patients' Immune System To Fight Disease Kite Pharma Cancer Treatment Stands Out In Hot CAR-T Field Novartis ( NVS ) is considering a sale of its dermatology generics drugs business as the Swiss health care giant seeks to shed some of its less profitable treatments and focus on growth areas such as cancer, according to people familiar with the matter. The business, which is mostly based in the U.S., could be valued at between [Read more]

IMPACT SNAPSHOT EVENT TIME: AAAP
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AAAP alerts
from News Quantified